Stockholm - Free Realtime Quote SEK
Egetis Therapeutics AB (publ) (EGTX.ST)
As of 4:54 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -0.29 | -0.31 | -1.06 | 0.36 |
| Low Estimate | -0.32 | -0.36 | -1.28 | 0.25 |
| High Estimate | -0.27 | -0.28 | -0.83 | 0.54 |
| Year Ago EPS | -0.3 | -0.3 | -1.3 | -1.06 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 6 | 5 |
| Avg. Estimate | 11.87M | 13M | 57.21M | 513.58M |
| Low Estimate | 8M | 10M | 40M | 320.6M |
| High Estimate | 15M | 17M | 76M | 657.3M |
| Year Ago Sales | 5.9M | 12.2M | 57.6M | 57.21M |
| Sales Growth (year/est) | 101.20% | 6.60% | -0.70% | 797.70% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.26 | -0.21 | -0.3 | -0.31 |
| EPS Actual | -0.3 | -0.3 | -0.3 | -0.3 |
| Difference | -0.04 | -0.09 | 0 | 0.01 |
| Surprise % | -15.40% | -42.90% | 0.00% | 3.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.29 | -0.31 | -1.06 | 0.36 |
| 7 Days Ago | -0.29 | -0.31 | -1.06 | 0.36 |
| 30 Days Ago | -0.29 | -0.29 | -0.99 | 0.26 |
| 60 Days Ago | -0.3 | -0.31 | -1.04 | 0.45 |
| 90 Days Ago | -0.33 | -0.35 | -1.16 | 0.72 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | EGTX.ST | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 3.30% | -- | -- | 3.60% |
| Next Qtr. | -3.30% | -- | -- | 7.90% |
| Current Year | 18.50% | -- | -- | 2.50% |
| Next Year | 134.00% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.87% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
VICO.ST Vicore Pharma Holding AB (publ)
8.67
+0.58%
ATORX.ST Alligator Bioscience AB (publ)
1.2080
-4.28%
ELIC-TO2.ST Elicera Therapeutics AB
0.3000
-34.50%
APTA.ST Aptahem AB (publ)
1.5750
-3.96%
ACE.ST Ascelia Pharma AB (publ)
2.1850
-0.91%
XBRANE.ST Xbrane Biopharma AB (publ)
0.2170
+20.56%
ELIC.ST Elicera Therapeutics AB (publ)
1.5100
-1.31%
BINV.ST BioInvent International AB (publ)
43.45
-3.01%
LYTIX.OL Lytix Biopharma AS
6.00
-1.64%
ONCO.ST Oncopeptides AB (publ)
2.0950
+0.48%